A nootropic is any substance taken to improve cognitive function, particularly memory, focus, learning, or mental clarity. The term was coined in 1972 by Romanian psychologist Corneliu Giurgea, combining two Greek words: “nöos” (thinking) and “tropein” (to guide). Today the word covers everything from your morning coffee to prescription medications, and the global nootropics market is valued at roughly $5.45 billion as of 2025, projected to more than double by 2033.
The Original Definition vs. Modern Usage
Giurgea didn’t intend for the word to apply to just any brain-boosting pill. He laid out specific criteria a substance had to meet: it should enhance learning, protect the brain against physical or chemical injury, improve communication between the two brain hemispheres, strengthen the brain’s higher-level control over lower reflexes, and critically, it should lack the sedation, stimulation, or other side effects typical of psychoactive drugs.
By that strict definition, very few substances actually qualify. In practice, the term has stretched far beyond Giurgea’s original framework. Marketers now apply “nootropic” to caffeine pills, herbal extracts, amino acids, synthetic compounds, and prescription drugs. Some of these have solid clinical evidence behind them. Many do not.
How Nootropics Work in the Brain
There’s no single mechanism that all nootropics share. Different substances affect the brain through different pathways, and some work through multiple pathways at once. The most common mechanisms fall into a few broad categories.
Some nootropics increase blood flow to the brain, delivering more oxygen and glucose to neurons. Others influence neurotransmitter systems, boosting the production or availability of chemical messengers involved in memory and attention. A third group provides neuroprotection, shielding brain cells from damage caused by stress, aging, or toxins. Still others supply raw materials the brain needs to function, essentially correcting nutritional shortfalls that were dragging cognitive performance down in the first place.
Common Natural Nootropics
The most widely used nootropic on earth is caffeine. It blocks a chemical in the brain that promotes drowsiness, which is why it makes you feel more alert. But caffeine alone can cause jitteriness and anxiety, which is where a popular pairing comes in. L-theanine, an amino acid found naturally in tea, appears to smooth out caffeine’s rough edges. A study in young adults found that roughly 100 mg of L-theanine combined with 40 mg of caffeine (about the amount in half a cup of coffee) significantly improved accuracy on attention-demanding tasks and increased self-reported alertness while reducing tiredness. That roughly 2:1 ratio of L-theanine to caffeine has become one of the most commonly recommended nootropic combinations.
Bacopa monnieri, an herb used for centuries in traditional Indian medicine, is one of the better-studied natural nootropics for memory. Multiple randomized, placebo-controlled trials using 300 mg of a standardized extract daily have found measurable improvements in the ability to retain new information, particularly delayed recall of word pairs. The catch is timing: benefits typically don’t appear until about 12 weeks of consistent use. One study found no cognitive effects at 5 weeks but clear improvements at 12 weeks, and another showed that cognitive gains persisted for at least 4 weeks after people stopped taking it. Bacopa appears to work best for retaining new information rather than speeding up reaction time.
Other natural nootropics with varying levels of evidence include ginkgo biloba, lion’s mane mushroom, Rhodiola rosea (an adaptogen used for mental fatigue), and omega-3 fatty acids. The strength of evidence varies widely across these, and many of the positive findings come from studies in older adults or people with existing cognitive impairment rather than healthy young people looking for a mental edge.
Synthetic and Prescription Nootropics
Piracetam, the first substance Giurgea developed and tested, launched the entire nootropic category. It’s prescribed in many European countries for cognitive impairment and dementia. However, a Cochrane review (the gold standard for evaluating medical evidence) found that despite widespread use, the evidence for piracetam’s effectiveness is poor in both quality and quantity. It remains unavailable as a prescription drug in the United States, though it sometimes appears in dietary supplements sold online.
Modafinil is a prescription wakefulness-promoting drug originally developed for narcolepsy and other sleep disorders. It has become one of the most popular off-label nootropics, particularly among students and professionals. Research suggests it can improve working memory, visual recognition, spatial planning, and the ability to stop impulsive responses, even in people who aren’t sleep-deprived. Interestingly, these benefits appear strongest in individuals with average or lower baseline cognitive ability. People who already score high on intelligence measures tend to see less improvement, possibly because their cognitive systems are already running near capacity.
Regulation and Safety Concerns
In the United States, the FDA does not approve nootropic supplements for treating, curing, or preventing any disease. Supplements can make “structure/function” claims (like “supports memory”) but cannot claim to treat conditions like Alzheimer’s or ADHD. Manufacturers are responsible for ensuring their products are safe before selling them, but the FDA does not test or verify supplements before they reach store shelves. This is a reactive system: the agency steps in only when problems surface.
The FDA has taken action against specific nootropic ingredients. Vinpocetine, a synthetic compound derived from the periwinkle plant and marketed as a brain supplement, prompted an FDA warning in 2019 specifically for women of childbearing age due to possible safety risks. Ephedrine alkaloids, once common in energy and focus supplements, were banned outright in 2004 because they presented an unreasonable risk of illness or injury.
Because nootropic supplements aren’t tightly regulated, what’s on the label doesn’t always match what’s in the bottle. Independent testing has found that some cognitive enhancement supplements contain undeclared pharmaceutical compounds, including piracetam, which is not approved as a dietary ingredient in the U.S. This makes buying from companies that submit to third-party testing particularly important.
Combining Nootropics: Stacking
Taking multiple nootropics together, called “stacking,” is common in the nootropic community. The idea is that substances working through different mechanisms can complement each other, like the caffeine and L-theanine combination mentioned above. Pre-made stacks are sold as single products containing several ingredients, while some people build their own custom combinations.
If you’re new to nootropics, the most practical approach is to start with a single ingredient at a low dose, give it enough time to evaluate (remembering that something like Bacopa needs 12 weeks), and track how you feel before adding anything else. This makes it possible to identify what’s actually working and what might be causing side effects. Jumping straight into a complex stack of five or six ingredients makes it nearly impossible to sort out which substance is responsible for any effect you notice, good or bad.
What the Evidence Actually Supports
The honest picture is mixed. For healthy young adults with no cognitive impairment, the benefits of most nootropics are modest at best. Caffeine reliably improves alertness and reaction time. L-theanine can take the edge off caffeine’s side effects. Bacopa has reasonable evidence for memory over months of use. Modafinil has the strongest evidence for cognitive enhancement in healthy people, but it’s a prescription drug with real side effects and legal restrictions.
For older adults experiencing age-related cognitive decline, certain nootropics have shown more consistent benefits, likely because there’s more room for improvement when baseline function has slipped. Many of the most impressive-sounding claims in nootropic marketing come from studies in elderly populations or people with diagnosed cognitive impairment, findings that don’t necessarily translate to a 25-year-old looking to be sharper at work. Reading the fine print on who was actually studied matters more than the headline claim on the label.